The report provides a detailed analysis essential for establishing a Guanadrel production plant. It encompasses all critical aspects necessary for Guanadrel production, including the cost of Guanadrel production, Guanadrel plant cost, Guanadrel production costs, and the overall Guanadrel production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Guanadrel production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Guanadrel is an antihypertensive drug primarily used for medical purposes, especially in the treatment of high blood pressure. It is widely used as a drug in the medical field for controlling high blood pressure by reducing the activity of certain nerves that tighten blood vessels.
It is generally used in patients who do not respond well to first-line antihypertensive medications. It works by affecting the nerves that control blood vessel constriction, which helps to lower blood pressure by allowing the vessels to relax. It is often used in pharmacological studies to help researchers understand how drugs influence nerve signalling and blood pressure regulation. It also serves as a reference compound in educational and research environments that focus on cardiovascular drug development.
The demand for Guanadrel is mainly driven by its use in the pharmaceutical industry as an antihypertensive medication for managing high blood pressure. Its application as a medication in hypertension treatment, particularly in patients who do not respond well to other medicines, largely promotes its demand in the medical and pharmaceutical industries. Its effectiveness in treating hypertension and related cardiovascular conditions significantly contributes to its market growth.
Its usage as a drug in the treatment of certain types of hypotension and its potential in other therapeutic applications also boost its demand in the medical sector. Its demand in the research and development industry to understand nerve-related blood pressure control mechanisms also contributes to its market expansion. Additionally, industrial Guanadrel procurement is influenced by factors such as the availability and cost of raw materials, including precursor chemicals, regulatory requirements, and environmental standards. Advances in production technology, along with reliable supply chains and sustainability efforts, also play a crucial role in shaping the global Guanadrel market. Efficient logistics and regulatory compliance further impact its production and distribution across various regions.
Raw Material for Guanadrel Production
According to the Guanadrel production plant project report, the major raw materials for Guanadrel production include Cyclohexanone, 3-Chloro-1,2-propanediol, Sodium Phthalimide, and S-Methylthiourea.
Production Process of Guanadrel
The extensive Guanadrel production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Guanadrel begins with the ketalization of cyclohexanone using 3-chloro-1,2-propanediol to form 2-chloromethyl-1,4-dioxaspiro[4,5]decane. Then, this intermediate is alkylated with sodium phthalimide, followed by alkaline hydrazinolysis to remove the phthalimide group and form 2-aminomethyl-1,4-dioxaspiro[4,5]decane. In the final step, the obtained compound is reacted with S-methylthiourea to introduce the guanidine moiety, which results in the formation of Guanadrel as the desired product.
Guanadrel appears as a white to off-white, odourless crystalline powder that is freely soluble in water and slightly soluble in alcohol. It is a sympatholytic antihypertensive agent that acts by inhibiting the release of norepinephrine from peripheral sympathetic nerve endings. The molecular formula of the compound is C10H19N3O2, and its molar mass is 213.28 g/mol. The compound reduces blood pressure by decreasing peripheral vascular resistance through sympathetic inhibition. Its melting point is around 213.5-215 degree Celsius. The density of the compound is 1.39 g/cm3, and it is generally stored at -20 degree Celsius. Moreover, prolonged exposure to the compound may cause adverse effects such as dizziness, hypotension, fatigue, and gastrointestinal disturbances.